Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “imatinib”
De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia
ClinicalTrials.gov study NCT01804985. IPD Sharing: Not stated. Countries: 1. Publications: 2.
IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.
ClinicalTrials.gov study NCT04357613. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
ClinicalTrials.gov study NCT02365441. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement
ClinicalTrials.gov study NCT00573326. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients
ClinicalTrials.gov study NCT00219765. IPD Sharing: Not stated. Countries: 1. Publications: 2.
L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors
ClinicalTrials.gov study NCT03426722. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00079313. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
ClinicalTrials.gov study NCT02272777. IPD Sharing: YES. Countries: 1. Publications: 0.
Imatinib as Pre-operative Anti-Colon Cancer Targeted Therapy
ClinicalTrials.gov study NCT02685046. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00866736. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Entacapone Combination With Imatinib for Treatment of GIST
ClinicalTrials.gov study NCT04006769. IPD Sharing: YES. Countries: 1. Publications: 5.
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
ClinicalTrials.gov study NCT04546074. IPD Sharing: NO. Countries: 1. Publications: 1.
The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML
ClinicalTrials.gov study NCT02204644. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation
ClinicalTrials.gov study NCT01744665. IPD Sharing: YES. Countries: 1. Publications: 0.
Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib
ClinicalTrials.gov study NCT01506336. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00769327. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
ClinicalTrials.gov study NCT05036135. IPD Sharing: NO. Countries: 26. Publications: 2.
Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)
ClinicalTrials.gov study NCT05722795. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00028847. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients
ClinicalTrials.gov study NCT04794088. IPD Sharing: UNDECIDED. Countries: 1. Publications: 22.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.